Galmed Pharmaceuticals ^{For Profit}

Galmed Pharmaceuticals is a drug development company that focuses on the next generation of metabolic and inflammatory therapeutics. They leverage science to deliver effective, safe, and tolerable lifetime medicine for inflammatory diseases based on their deep understanding of drug research and development, breakthrough mechanisms of action, and global collaborations. The company has a pipeline, and it is currently conducting the ARMOR Phase 3 Study. Contact_info: N/A.